Format

Send to

Choose Destination
Clin Pharmacol Ther. 2019 May;105(5):1091-1094. doi: 10.1002/cpt.1268. Epub 2018 Dec 4.

Pharmacogene Variation Consortium Gene Introduction: NUDT15.

Author information

1
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
2
Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
3
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
4
Sema4, a Mount Sinai Venture, Stamford, Connecticut, USA.
5
Department of Pediatrics, Section of Genomic Pediatrics and Children's Research Institute, The Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
6
RPRD Diagnostics LLC, Wauwatosa, Wisconsin, USA.
7
Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
8
Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany.
9
Department of Clinical Pharmacy, School of Pharmacy, Kitasato University, Shirokane, Minato-ku, Tokyo, Japan.
10
Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
11
University of Tübingen, Tübingen, Germany.
12
Center for Pediatric Genomic Medicine, Children's Mercy Kansas City, Kansas City, Missouri, USA.
13
School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
14
Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.
PMID:
30515762
PMCID:
PMC6465081
[Available on 2020-05-01]
DOI:
10.1002/cpt.1268

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center